CY1114108T1 - AMINO-Heterocyclic Compounds Used as PDE9 Suspensions - Google Patents

AMINO-Heterocyclic Compounds Used as PDE9 Suspensions

Info

Publication number
CY1114108T1
CY1114108T1 CY20131100559T CY131100559T CY1114108T1 CY 1114108 T1 CY1114108 T1 CY 1114108T1 CY 20131100559 T CY20131100559 T CY 20131100559T CY 131100559 T CY131100559 T CY 131100559T CY 1114108 T1 CY1114108 T1 CY 1114108T1
Authority
CY
Cyprus
Prior art keywords
pde9
suspensions
amino
compounds used
heterocyclic compounds
Prior art date
Application number
CY20131100559T
Other languages
Greek (el)
Inventor
Michelle Marie Claffey
Christopher John Helal
Patrick Robert Verhoest
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10701921.8A external-priority patent/EP2389382B1/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of CY1114108T1 publication Critical patent/CY1114108T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση παρέχει ενώσεις αναστολείς ΡDΕ9 του Τύπου (Ι) και φαρμακευτικώς αποδεκτά άλατα αυτών, όπου τα R1, R2, R3, A και n είναι όπως ορίζεται εδώ. Επίσης παρέχονται φαρμακευτικές συνθέσεις που περιέχουν τις ενώσεις του Τύπου Ι και χρήσεις αυτών στην θεραπεία νευροεκφυλιστικών και γνωστικών διαταραχών, όπως ασθένεια Alzheimer και σχιζοφρένεια.The invention provides PDE9 inhibitor compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, A and n are as defined herein. Also provided are pharmaceutical compositions containing the compounds of Formula I and their uses in the treatment of neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia.

CY20131100559T 2009-01-26 2013-07-04 AMINO-Heterocyclic Compounds Used as PDE9 Suspensions CY1114108T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20609209A 2009-01-26 2009-01-26
EP10701921.8A EP2389382B1 (en) 2009-01-26 2010-01-13 Amino-heterocyclic compounds used as pde9 inhibitors

Publications (1)

Publication Number Publication Date
CY1114108T1 true CY1114108T1 (en) 2016-07-27

Family

ID=58448995

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100559T CY1114108T1 (en) 2009-01-26 2013-07-04 AMINO-Heterocyclic Compounds Used as PDE9 Suspensions

Country Status (1)

Country Link
CY (1) CY1114108T1 (en)

Similar Documents

Publication Publication Date Title
CY1112332T1 (en) Amino-heterocyclic compounds
UY32391A (en) AMINO-HETEROCYCLIC COMPOUNDS
CY1123524T1 (en) SUBSTITUTE COLORS AND METHOD OF USE
UY30641A1 (en) DERIVATIVES OF 2- [1H-PIRAZOL-5-IL] AND 2- [2H-PIRAZOL-3-IL] HAVE [3,2-C] REPLACED PYRIDINS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND APPLICATIONS
CY1123025T1 (en) BROMOIQUERATE INHIBITORS
CY1108347T1 (en) IMIDAZOLI UNIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
CY1124631T1 (en) 11-Substituted 24-HYDROXYSTEROLS FOR USE IN THE TREATMENT OF NMDA-RELATED DISORDERS
CY1110115T1 (en) ACGYLENYL-PYRAZOLO-PYRIMIDINE PRODUCERS AS MGLUR2 COMPONENTS
CY1110952T1 (en) KINOCLIDIN PRODUCTION AND USE OF THESE MUSCARINIAN M3 RECEPTOR COMPONENTS
MX2014012695A (en) Isoindolone derivatives.
CY1112311T1 (en) PYRAZOLIN COMPOUNDS AS COMPETITIVES OF SALT CORTICIDE
CY1117105T1 (en) PYRIDAZINONIN COMPOUNDS AND USE AS DAAO SUSPENSIONS
CY1109348T1 (en) DIHYDRO-SULFUR-PYRIMIDES FOR THE TREATMENT OF INFLAMMATORY PATIENTS
NZ596579A (en) Bace inhibitors
CY1113846T1 (en) PYRIMIDINIS DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF ASTHMA, COPD, ALLERGIKIS RINITIDAS, ALLERGIKIS EPIPEFYKITIDAS, ATOPIKIS DERMATITIDAS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, bacterial infections and DERMATOSIS
MY169274A (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
CY1113339T1 (en) IMIDAZOKINOLINS WITH IMMUNO-REGULATORY PROPERTIES
CY1110247T1 (en) Benzokinazoline derivatives and their use in the treatment of bone disorders
CY1108843T1 (en) 3,11B CIS DIMRODETRETRAVENASINE FOR THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOLOGIES
CY1114382T1 (en) 2-Cyanophenyl Synthetic Heterocyclic Compounds, and their Compositions and Uses
CY1114140T1 (en) 4-PYRIDINONE COMPONENTS AND THEIR USE FOR CANCER
UY30310A1 (en) 2-AZETIDINONE DERIVATIVES, SALTS, SOLVATES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
DK1689721T3 (en) Aminopyrazole derivatives as GSK-3 inhibitors
CY1112708T1 (en) [1H-INDOLO-5-MATERIAL) -THETROARYLOXY] - (1-AZA-BICYCLE [3.3.1] NON-ASCHR NON-ACCHR CHINESE CONNECTORS FOR TREATMENT THERAPEUTICS
CY1118623T1 (en) TETRAHYDROPYROLTHIAZINE COMPOUNDS AS BACE Suspensions